Sentynl Therapeutics, Inc. v. U.S. Specialty Insurance Co

Good Law
United States Court of Appeals for the Ninth CircuitMarch 9, 202221-55370California1,107 words

Opinion

Opinion

NOT FOR PUBLICATION FILED

UNITED STATES COURT OF APPEALS MAR 9 2022

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS

FOR THE NINTH CIRCUIT

SENTYNL THERAPEUTICS, INC., a No. 21-55370 California corporation, D.C. No. Plaintiff-Appellant, 3:19-cv-01667-LAB-AHG

v.

MEMORANDUM*

U.S. SPECIALTY INSURANCE

COMPANY, a Texas corporation,

Defendant-Appellee.

Appeal from the United States District Court for the Southern District of California Larry A. Burns, District Judge, Presiding

Argued and Submitted January 11, 2022 Pasadena, California

Before: RAWLINSON and CALLAHAN, Circuit Judges, and BLOCK,** District Judge.

Sentynl Therapeutics, Inc. (“Sentynl”), appeals the district court’s summary

judgment holding that certain costs were not covered by a directors, officers and

* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. ** The Honorable Frederic Block, United States District Judge for the Eastern District of New York, sitting by designation. organization policy issued to Sentynl by U.S. Specialty Insurance Company…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.